Share this article

Lymphovenous bypass surgery for the treatment of Kaposi sarcoma-associated lymphoedema

Blade Olson, Christian Jimenez, Emma Koesters, Ketan M Patel
15 August 2022

Lymphoedema is a sequela of Kaposi sarcoma (KS) that often does not respond adequately to chemoradiotherapy and complete decongestive therapy (CDT). Lymphovenous bypass (LVB) is an option for patients whose lymphedema persists despite conservative treatment. We present the case of a 59-year-old man with a diagnosis of KS due to human immunodeficiency virus (HIV), who presented with progressive, bilateral lower-extremity swelling refractory to CDT. This patient’s lymphoedema was successfully treated with LVB, illustrating the applicability of LVB for the treatment of KS-associated lymphoedema.

Free for all healthcare professionals

Sign up to the Wounds Group journals

By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.